Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 16 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patientsWilloughby, S.; Rajendran, S.; Chan, W.; Procter, N.; Leslie, S.; Liberts, E.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.
2011Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin DNgo, D.; Chan, W.; Rajendran, S.; Heresztyn, T.; Amarasekera, A.; Sverdlov, A.; O'Loughlin, P.; Morris, H.; Chirkov, Y.; Norman, R.; Horowitz, J.
2013Enhanced NO signaling in patients with Takotsubo cardiomyopathy: short-term pain, long-term gain?Nguyen, T.; Neil, C.; Sverdlov, A.; Ngo, D.; Chan, W.; Heresztyn, T.; Chirkov, Y.; Tsikas, D.; Frenneaux, M.; Horowitz, J.
2014Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valveAli, O.; Chapman, M.; Thanh, H.; Chirkov, Y.; Heresztyn, T.; Mundisugih, J.; Horowitz, J.
2013Determinants of prolonged impairment of global longitudinal strain post Takotsubo cardiomyopathyNguyen, T.; Neil, C.; Singh, K.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.; European Society of Cardiology Congress 2013 (ESC 2013) (31 Aug 2013 - 04 Sep 2013 : Amsterdam, NETHERLANDS)
2013Premature aging of cardiovascular/platelet function in polycystic ovarian syndromeChan, W.; Ngo, D.; Sverdlov, A.; Rajendran, S.; Stafford, I.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.
2015Impaired platelet nitric oxide response in patients with new onset atrial fibrillationProcter, N.; Ball, J.; Liu, S.; Hurst, N.; Nooney, V.; Goh, V.; Stafford, I.; Heresztyn, T.; Carrington, M.; Ngo, D.; Hylek, E.; Isenberg, J.; Chirkov, Y.; Stewart, S.; Horowitz, J.
2007Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA)Ngo, D.; Heresztyn, T.; Mishra, K.; Marwick, T.; Horowitz, J.
2007An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerationsHorowitz, J.; Heresztyn, T.
2011The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterloadSverdlov, A.; Ngo, D.; Nightingale, A.; Rajendran, S.; Mishra, K.; Heresztyn, T.; Ritchie, R.; Marwick, T.; Frenneaux, M.; Horowitz, J.